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1. Introduction 
Discussions on receptors involved in estrogen action(Stanišić et al,2010) have so far focused 
on the two major forms of “classical” estrogen receptors, the estrogen receptor ǂ (ER ǂ) and 
estrogen receptor ǃ (ER ǃ). Both are DNA binding as well as hormone binding forms, with 
distinct, well-characterized functional domains. The differences between the two have 
mainly been in their respective molecular masses and shapes and in the target genes with 
which they interacted. 
I have been involved in research in estrogen action for 4 decades and more. Since the focus 
of my work was chiefly on non-conventional estrogen receptors and receptor associated 
proteins, often the progress made was felt by me as slow.Nevertheless,it is my sincere belief 
that what has been unveiled in this direction over the years have not gone unproductive. 
The two proteins that have been identified in this context, one a non DNA binding estrogen 
receptor and the other a transcription factor that dimerises with this receptor in the nucleus, 
have pointed towards the existence of a unique system of receptor in estrogen action. For 
the first time ever, it has become clear that there is a form of estrogen receptor whose 
primary functional role is in post transcriptional regulatory mechanisms that include 
splicing, nucleocytoplasmic transport of RNA and finally, the translation of mRNA. Also, 
deeper insights into the functional biology of the transcription factor have unfolded certain 
experimental data hitherto unknown in the literature on steroid hormone action. What is 
being discussed in this chapter deals exclusively with these two proteins, one a plasma 
membrane localized estrogen receptor which moves into the nucleus to involve itself in gene 
regulatory events and the other a transcription factor with a parallel functional role in 
mitochondrial steroidogenesis 
2. The concept of steroid hormone receptor activation 
The favorite theme of the 60’s and early 70’s in descriptions of steroid hormone action, 
particularly with reference to estrogen action, used to be that the receptor primarily existed 
in the cytosol. Upon hormone binding and the consequent “receptor activation” the receptor 
entered the nucleus and interacted with the genetic elements. This “two-step mechanism”, 
independently proposed by the research groups led by Jensen and Gorski (Jensen & 
DeSombre, 1973; Shyamala & Gorski, 1969; Mohla et al, 1972) formed the basis for all 
subsequent discussions on intracellular movements of the receptor –steroid hormone 
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complex. It was proposed that the cytosolic receptor existed as a high molecular weight 
form that sedimented at 8-9S in low salt linear sucrose gradients. Later studies have 
revealed that in this cytosolic form, the receptor with an average sedimentation value of 4S, 
remained in association with heat shock protein 90(hsp 90) when there was no hormone 
bound to it (Pratt, 1990; Pratt &Toft, 1997). Hormone binding to the receptor initiated 
dissociation of the receptor form Hsp-90, which formed a key event in steroid receptor 
activation (Pratt, 1990). One of the major structural changes noticed in the receptor during 
its activation was the transformation of the 4S receptor to a form that sedimented at 5S in 
sucrose gradients containing 0.3M KCl (Shyamala & Gorski, 1969). 
The 4S-5S conversion was the target of several hypotheses that attempted to explain the 
molecular event. In the Hsp-90 model, it was clear that association of the receptor with Hsp-
90 prevented the nuclear migration of the receptor the reason for which was not clear at that 
time. It was the first ever report on the sequencing of amino acids of the human estrogen 
receptor ǂ (ER ǂ) by Chambon’s group at Strasburgh that paved the way for a number of 
active studies in this direction (Green & Chambon, 1987 a, b). The identification of the 
nuclear localization signal (NLS) in ERǂ (Kumar et al., 1986; Kumar et al., 1987) was one 
such landmark observation. Thampan’s group subsequently extended the studies using ERǂ 
isolated from goat uterus and purified and characterized a 55kDa protein (p55) that 
apparently recognized the nuclear localization signal (NLS) on ERǂ and initiated the nuclear 
entry of the receptor (Nirmala & Thampan,1995 a,b). The studies reported by Thampan’s 
group gave additional validity to the role of p55 in the nuclear entry of ERǂ. 
3. The role of estradiol in the nuclear entry of ERα 
Sai Padma et al (2000)and Sai Padma & Thampan(2000) observed that there were three 
nuclear proteins that contributed to the regulated entry of ERǂ into the nuclei. (a) the p55 
that recognized the NLS on ERǂ(b)a 28kDa protein,p28 that bound to the NLS signal on ERǂ 
and thereby prevented the p55-ERǂ interaction;(c)a 73 kDa protein,p73 that bound to the 
hormone binding domain(HBD)on ERǂ.Under hormone free conditions,p28 remained 
bound to the ERǂ NLS,blocking the NLS recognition by p55.Estradiol binding to the HBD 
and the consequent conformational change in the HBD brought the HBD-bound p73 in close 
interaction with p28.This resulted in the dissociation of p28 from the NLS which was 
subsequently occupied by p55.The interaction culminated in the nuclear entry of ERǂ,also 
mediated by the cytoskeletal elements, actin and tubulin(14). 
4. Search for the “receptor-activator” protein and the discovery of E-RAF 
There was a line of thinking that originated from Notides’(Notides & Nielson,1974)and 
Yamamoto’s (Yamamoto,1974)laboratories that in estrogen action there was a possibility for 
the involvement of a DNA binding X-protein in converting the non-DNA binding estrogen 
receptor to a DNA binding form. Based on these observations and consideration of a 
potential possibility that a non-hormone binding transcription factor could be involved in 
the “activation” process, Thampan and Clark (1981,1983) presented the first ever 
experimental evidence for the existence of an estrogen receptor activation factor (E-RAF) in 
the rat uterus. A parallel thinking that contributed to the design of experiments was the 
already available information that many transcription factors were moderately basic 
proteins and also that such proteins failed to bind to DEAE cellulose. It was this information 
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that primarily led to the separation of E-RAF from the estrogen receptor that it dimerises 
with during DEAE-cellulose chromatography. Thampan and Clark (1981) reported that a 3S 
protein of the rat uterine cytosol, that appeared in the DEAE cellulose flow through fraction, 
promoted the DNA binding of a specific class of non-DNA binding estrogen receptor. 
Thampan (1987,1989) in his reports on the purification of E-RAF observed that E-RAF 
existed in two molecular forms, E-RAF II and I. 
While both forms displayed identical molecular weight of 66kDa, their molecular shapes 
appeared to be different as displayed by the results of gel filtration chromatography and 
also in their dissimilar sedimentation behavior in linear sucrose density gradients. 
Functional assays were carried out in which the proteins were incubated with labeled DNA, 
which was subsequently exposed to S1 nuclease in order to digest the single stranded 
regions. The results showed that while E-RAF II destabilized DNA double helix and 
enhanced strand separation, the reverse property (stabilization of double helical structure) 
was found associated with E-RAF I. In vitro transcription assays involving isolated nuclear 
RNA polymerases also highlighted this differential behavior of the two molecular forms. 
While E-RAF II enhanced transcription, in a system containing nuclear RNA polymerase 
purified from goat uterine nuclei, E-RAF I inhibited transcription in a dose-dependent 
manner. 
5. A vision into the molecular identity of the type I and type II nuclear 
estrogen binding sites 
The report in which functional characterization of E-RAF was described (Thampan,1989), 
also presented a method for the assay for E-RAF in association with the nuclear RNA 
polymerases. Nuclear RNA polymerases were extracted from isolated rat uterine nuclei and 
subjected to partial purification through chromatography on DEAE Sephadex A-25 and 
elution with linear (NH4)2SO4 gradient. Ovariectomized rats were used in this study. While 
control rats received injection of the vehicle alone, experimental animals were subjected to 
subcutaneous injections of 3μg estradiol-17ǃ for a duration of one hour. The RNA 
polymerase fractions derived from both control and experimental nuclei and eluted from 
DEAE-Sephadex A-25 column were subjected to the nuclear exchange assay that was 
developed earlier by Clark and coworkers (Clark & Peck,1979;Clark et al.,1979). It was 
through this nuclear exchange assay that Clark’s group had demonstrated the existence of 
type I and type II estrogen binding sites in rat uterine nuclei (Eriksson et al.,1978). 
Following DEAE Sephadex-A25 chromatography of nuclear sonicates, the fractions collected 
were subjected to the estradiol exchange assay as well as RNA polymerase assay with calf 
thymus DNA as the template .RNA polymerase peaks representing I, II, IIIa and IIIb were 
clearly demonstrated in the DEAE-Sephadex A-25column fractions. Also demonstrated was 
the estrogen binding function associated with all four peaks of RNA polymerase activity. 
The ‘receptor’ activity associated with the RNA polymerase II was subjected to further 
analysis. Sucrose density gradient analysis displayed two peaks of activity, a small peak at 
5S and a large peak at 3S.While the 5S peak was distinctly DNA binding, the 3S peak which 
represented the major share of receptor activity, remained non DNA binding. Subsequent 
studies (Thampan,1989) have demonstrated that the DNA binding function of the 5S peak 
was due to the presence of E-RAF and an estrogen receptor that dimerised with E-RAF 
while the non DNA binding 3S fraction was represented by a receptor that did not dimerise 
with E-RAF.The same studies have concluded, subsequently that the receptor of the 5S peak 
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was the non activated estrogen receptor (naER),a glycoprotein and a tyrosine kinase 
sensitive to the presence of estradiol and primarily localized at the plasma 
membrane(Karthikeyan & Thampan,1994). The naER was the only estrogen receptor that 
could dimerise with E-RAF.The 3S peak on the other hand, represented the nuclear estrogen 
receptor II (nERII), a tyrosine kinase insensitive to the presence of estradiol. The nuclear 
estrogen receptor II failed to dimerise with E-RAF, the obvious reason being the changes 
induced in naER conformation during its transformation to nERII (Karthikeyan & 
Thampan,1995;Thampan et al.,1996). The naER to nERII transformation was accomplished 
by a 61kDa nuclear naER-transforming factor (naER-TF), originally reported by Jaya and 
Thampan (2000). 
6. Factors regulating nuclear entry of E-RAF 
Endoplasmic reticulum is the primary site of localization of intracellular E-RAF.A 55kDa 
anchor protein, ap55, that binds estradiol with high affinity retains E-RAF at the 
endoplasmic reticulum (Govind et al.,2003 a,b). Figure 1 displays the immunolocalisation of 
E-RAF in the endoplasmic reticulum of a goat uterine cell.  
E-RAF remains anchored to ap55, through the mediation of a 66kDa nuclear transport 
protein, tp66. The tp66 recognizes the NLS in E-RAF.Within the E-RAF-tp66 complex, tp66 is 
anchored by ap55 in an estrogen dependent manner. Presence of saturating levels of 
estradiol maintains a specific conformation of ap55 that keeps tp66-E-RAF complex 
anchored to it. Lowering of estradiol concentration results in altered ap55 conformation that 
facilitates the release of tp66-E-RAF complex from ap55. The complex moves to the nucleus 
during which tp66 gets docked to a 38kDa nuclear pore-complex protein, npcp38. E-RAF 
enters the nucleus. 
E-RAF is a high affinity progesterone and cholesterol binding protein (Thampan et al., 2000). 
Under both conditions E-RAF dissociates from the ap55-tp66 complex and migrates to the 
nucleus (possibly also to the mitochondria as cholesterol bound form). Premkumar et 
al(1999)presented information on the functional domains of E-RAF.Nuclear run on 
transcription studies were carried out in order to identify the genes influenced by E-RAF.For 
this, subtractive hybridization approach was attempted (Jacob,2006). Free E-RAF which can 
be transported to the nuclei by tp66, and progesterone bound E-RAF that gets transported to 
the nuclei on its own displayed totally distinct response patterns. It was a 55kDa nuclear 
pore complex protein (npcp55) that docked progesterone bound E-RAF at the pore complex. 
On the contrary, the free E-RAF-tp66 complex was docked to npcp-38. While free E-RAF 
was found to enhance the expression of splicing factor(s) genes, a major gene that was 
shown to be influenced by progesterone bound E-RAF was the collagenase(s) gene(s). The 
gene(s) if any, that are under the regulatory influence of cholesterol bound E-RAF remain to 
be known. Also the nuclear pore complex protein that docks cholesterol bound E-RAF is to 
be identified. 
It appears that cholesterol is a natural regulator of E-RAF mediated gene expression 
(Thampan et al,2000). The presence of an inhibitor that prevented the dimerisation between 
E-RAF and naER in goat uterus was recognized early in E-RAF studies. The inhibition in the 
formation of E-RAF –naER heterodimer and the subsequent decline in the nuclear binding 
of the receptor was the assay target employed for the identification of this inhibitor. GC-MS 
analysis of the purified molecule showed its identity as unmetabolised cholesterol 
(Thampan et al,2000). 
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(A)The cells were fixed, permeabilised and exposed to rabbit anti-goat E-RAF IgG, followed by Cy3 
labeled anti rabbit IgG. 
(B)The cells were also stained with DiOC6 (3) to highlight the endoplasmic reticulum. 
(C)The merged figures created by confocal microscopy clearly showed that endoplasmic reticulum is 
the primary site of localization of E-RAF. 
Fig. 1. Intracellular association of E-RAF with endoplasmic reticulum in goat endometrial 
cells in culture. A primary culture of goat endometrial cells was exposed to estradiol-free 
medium for 48 hours following which the cells were examined under a Leica confocal 
microscope. 
7. E-RAF in pregnant rat uterus: significance of the findings 
Premkumar and Thampan (1995) examined the level of E-RAF in the uteri of pregnant rats 
during a full term of pregnancy. It was noticed that from day 1 of pregnancy the E-RAF titer 
in the uterus registered a steady increase. It reached an all time peak towards mid-
pregnancy following which E-RAF level began to decline. The rate of decline was found to 
be very fast; two days before parturition the uterine E-RAF titer became virtually 
undetectable. It is known that progesterone is essential for maintaining the functional 
integrity of the pregnant uterus. The possibility, therefore, exists that the E-RAF titer is a 
reflection of the progesterone requirement of the pregnant uterus. The decline in E-RAF titer 
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during the second half is again indicative of the need for progesterone withdrawal prior to 
parturition. The hypothetical presentation given in figure 2 takes into account the E-RAF 





Fig. 2. A generalized plan of E-RAF titer in rat uterus during pregnancy. Uterine tissue 
was collected from a group of rats everyday during the 21-day pregnancy term. The tissue 
samples were homogenized in the coating buffer (10mM carbonate and 40mM bicarbonate 
buffer, pH 9.6), and the homogenates were centrifuged at 10,000Xg for 15 minutes. To the 
supernatant an equal volume of a suspension of DEAE cellulose in coating buffer was 
added. After 30 minutes of incubation in ice, the DEAE cellulose flow through fraction was 
collected. An aliquot of this fraction was used for E-RAF estimation through ELISA. The 
data takes into account the potential existence of an intracellular threshold level of E-RAF. It 
is being postulated that, beyond this threshold E-RAF enters the blood and gets transported 
to the specified site that, under conditions where E-RAF titer is low releases the hypothetical 
factor which, upon binding to its receptor on the uterine cell membrane, initiates the signal 
transduction events leading to enhanced E-RAF gene expression. 
During the negative regulatory mechanism the enhanced level of E-RAF could inhibit the 
release of the stimulatory factor, thereby suppressing the signal transduction process 
leading to E-RAF gene activation. 
If one assumes that there is an upper limit (threshold) in the uterine level of E-RAF, beyond 
which the E-RAF enters the blood, it is possible to reconstruct a molecular event. E-RAF is 
probably transported by the blood to an anatomical site (brain?), which is responsible for 
enhancing uterine E-RAF gene expression through distinct signal transduction mechanisms 
mediated by a specific macromolecular agent. Possibly, the presence of E-RAF in circulation 
could inhibit the release of this mediator, the eventual result being the decline in E-RAF 
synthesis, leading to the final disappearance of the proteins prior to parturition. Figure 3 
illustrates the proposed mechanism of action of this hypothetical regulator of E-RAF gene 
expression in uterine cells.  
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(1) Blood plasma (2) Target cell(3)E-RAF-GRA(E-RAF gene regulatory agent)(4)receptor for E-RAF-
GRA(5)signal transduction events that succeed the receptor –GRA-interaction(6)E-RAF gene 
expression(7)synthesis of E-RAF in the cytoplasm. 
Fig. 3. A model that explains the role of an external factor, transported by the blood, on 
uterine E-RAF synthesis. The factor recognizes its receptor on the target cell plasma 
membrane and induces signal transduction events which eventually terminate in enhanced 
expression of E-RAF gene.  
The model indicates that the regulatory factor,E-RAF gene regulatory agent(E-RAF-GRA) 
transported by the blood, binds to its receptor on the plasma membrane of the uterine cell. 
This interaction initiates a cascade of signal transduction events, ultimately leading to the 
enhancement in E-RAF gene expression in the nucleus and synthesis in the cytoplasm. The 
decline in the circulating presence of the factor, as it may happen during the second half of 
pregnancy, will be reflected in the decline in uterine E-RAF gene expression. Preliminary 
report has already been made on the presence of E-RAF in the goat uterine mitochondria 
(Praseetha & Thampan,2009). Possibly one of the major functions of E-RAF is to transport 
cholesterol to the mitochondria where it will be converted enzymatically to pregnenolone 
and progesterone.  
8. E-RAF and mammary cancer 
E-RAF could play a role in the progression of mammary cancer. E-RAF II is a very active 
transcription factor and this molecular form of E-RAF represents more than 75%of total E-
RAF population representing both E-RAFI and E-RAF II. If one assumes that the benign to 
malignant transformation of the mammary cancer is associated with enhanced expression of 
E-RAFII, that should be reflected in immunofluorescent detection of E-RAF in frozen 
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biopsies of mammary tissue. Figure 4 presents the results of a recent study carried out in 
this direction where the tissue sections were exposed first to anti E-RAF IgG and 
subsequently to FITC labeled secondary antibody. There is a dominating presence of E-RAF 
in the cytoplasm and also in the nuclei (primarily stained with propidium iodide).  
 
 
A cryostat section of human breast cancer biopsy was fixed, permeabilised and exposed overnight to 
rabbit anti goat E-RAF IgG at 40C.Further exposure of the section to goat anti rabbit IgG labeled with 
FITC was conducted in the dark for 1 hr following which the nuclei were stained with propidium 
iodide. The sections were examined using a Leica fluorescence microscope. The green fluorescence 
indicates the cytoplasmic presence of E-RAF.The nuclei are stained red with propidium iodide. 
However the presence of E-RAF in the nuclei is marked by the transition of the red colour to light 
orange and even yellow. 
Fig. 4. Detection of E-RAF in human breast cancer biopsy. 
If what I discussed in the previous paragraph regarding the brain derived regulator of E-RAF 
gene expression is proven correct, it is possible to suggest that defects in this regulatory 
protein mechanism and its action could lead to uncontrolled expression of the E-RAF gene. 
How does this enhanced expression of E-RAF gene influence mammary cancer progression 
remains to be seen. One of the major molecular targets of progesterone bound E-RAF is the 
collagenase gene. Whether the progesterone bound E-RAF mediated enhancement in 
collagenase gene expression has any role in mammary cancer metastasis is yet to be examined. 
9. Multiple intracellular sites for E-RAF action 
Recent observation regarding the positive presence of E-RAF in goat uterine mitochondria is 
indicative of a possible functional role for E-RAF in the mitochondria. Confocal microscopic 
studies conducted on goat endometrial cells in culture with exposure to varying 
concentrations of estradiol or progesterone showed that while 3-5nM concentrations of 
estradiol helped in the nuclear entry of E-RAF, progesterone mediated nuclear entry was 
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found to be effective only in the presence of 15-16nM progesterone. The corresponding 
effects produced in the presence of different concentrations of cholesterol remains to be 
seen. The postulate that the enhancement in E-RAF titer in the pregnant uterus is an indirect 
reflection of the progesterone production in the uterus during the first half of pregnancy 
takes into account the possibility that mitochondrial steroidogenesis in the uterine cell is 
under E-RAF control. As mentioned earlier, E-RAF may function as a cholesterol transporter 
to the mitochondrial steroidogenic site, eventually facilitating the conversion of cholesterol 
to pregnenolone and progesterone. The nuclear genes influenced by cholesterol-bound E-
RAF could well be those the products of expression of which are constituents of the 
mitochondrial steroidogenic complex like cytochrome P450(Fig.5) 
 
 
(1) Nucleus (2) Genes (3) Endoplasmic reticulum (4) Mitochondria (5) (5A) and (5B) Nuclear pore 
complex proteins that bind free E-RAF, progesterone-bound E-RAF and cholesterol bound E-RAF 
respectively. (6) ap55 (6A) Estradiol-bound ap55 (7) tp66 (7A) tp66-E-RAF complex (8) Free E-RAF (9) 
Progesterone bound E-RAF (10) Cholesterol bound E-RAF. 
Fig. 5. Mode of action of E-RAF in the target cell. 
The primary site of intracellular location of E-RAF is the endoplasmic reticulum where it 
remains anchored to the anchor protein 55(ap55) through the mediation of tp66 (transport 
protein 66) in an estrogen dependent manner.tp66 transports E-RAF to the nucleus, after 
dissociation from ap55, when the intracellular level of estrogen declines. When bound 
by cholesterol or progesterone, E-RAF dissociates from tp66 and moves independently to 
the nucleus. The nuclear entry of E-RAF again is regulated by nuclear pore complex 
proteins (npcp). Apparently it is the conformation of E-RAF that determines the identity 
of npcp with which it should interact. There is a distinct possibility that within the 
nucleus free E-RAF, progesterone bound E-RAF and cholesterol bound E-RAF recognize 
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and regulate the expression of specific sets of genes, possibly influenced by specific 
acceptor proteins. 
Mitochondria appears to be the other target of cholesterol bound E-RAF.The possibility 
exists that E-RAF functions as a cholesterol transporter to mitochondria, favoring the 
conversion of cholesterol to pregnenolone and progesterone.This higher titer of E-RAF 
should be reflected in higher production of uterine progesterone that could eventually 
contribute to the maintenance of the pregnant uterus during the first half of pregnancy. 
10. Identification of the estrogen receptor that dimerizes with E-RAF 
The experimental observations on the goat uterine E-RAF signals a clear indication that a 
special class of estrogen receptor dimerised with E-RAF within the nucleus. A DNA 
cellulose binding assay was developed in which the non-DNA binding estrogen receptor 
was labeled with 3H-estradiol and the binding of the hormone-receptor complex to DNA 
cellulose in the presence of E-RAF was quantitated. Anuradha et al (1994) reported on the 
isolation and characterization of a 66kDa, high affinity estrogen binding protein from the 
goat uterus. The receptor displayed the same affinity to bind estradiol as that of the estrogen 
receptor ǂ (ER ǂ). In view of its inability to bind to DNA on its own, this new estrogen 
receptor was designated as non-activated estrogen receptor (naER). 
A method was developed for the isolation of the non-DNA binding estrogen receptor that 
dimerized with E-RAF.The method involved preparation of goat uterine cytosol, 
collection of the DNA-Sepharose unadsorbed fraction, successive ion exchange 
chromatography over DEAE cellulose and phosphocellulose and finally Hsp 90 Sepharose 
chromatography in the presence of sodium molybdate, achieving final elution with zero 
molybdate buffer (Anuradha et al.,1994). While showing its distinctiveness over ERǂ, as a 
non DNA binding protein, the naER further demonstrated its function as a glycoprotein 
and a tyrosine kinase (Karthikeyan & Thampan,1996). The tyrosine kinase property was 
sensitive to the presence of estradiol: the enzyme activity was totally inhibited in the 
presence of the hormone at concentrations which saturated its binding sites. The 
observation was a clear indication to the possibility that the naER tyrosine kinase activity 
can become functional only after naER undergoes a critical structural change within the 
cell. 
Direct biochemical analysis showed that plasma membrane is the primary site of 
localization of naER (Karthikeyan & Thampan,1996). The possibility of plasma membrane 
being a site of intracellular localization of estrogen receptor was first proposed by Pietras 
and Szego (1975,1977) several years ago. Sreeja and Thampan (2004 a,b) demonstrated that 
naER dissociated from the plasma membrane following exposure to estradiol. This was 
shown to be an estrogen-specific phenomenon since non-estrogenic steroids failed to bring 
about the dissociation while the non steroidal estrogen, diethylstilbestrol was as effective 
as estradiol-17ǃ in inducing naER dissociation from the plasma membrane. What was 
unique in this observation was that the dissociation of naER appeared to be an energy 
dependent process. The involvement of a Ca++/Mg++dependent ATPase in the process was 
evident. Enhancement of the ATPase activity was dependent on exposure of the membrane 
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11. Protein protein interactions during naER internalization following 
estradiol binding 
The studies reported from our laboratory (Sreeja & Thampan, 2004 b) have indicated that 
the internalization of naER from the plasma, following estradiol binding to the receptor was 
a clathrin-coated vesicle (CCV)-mediated mechanism. A 55 kDa protein of the CCV, 
apparently carrying the internalization signal (Trowbridge at al, 1993) is the target protein 
for naER in CCV. The internalized naER interacts with a 58kDa nuclear transport protein, 
the actin binding p58, that recognizes the nuclear localization signal (NLS) on the receptor. 
Prior to recognizing p58, the site involved on the naER is bound by Hsp-90.Estradiol 
binding to naER promotes dissociation of Hsp-90 from the receptor (Anilkumar at al., 2010). 
Confocal microscopic studies presented in this study showed that in goat endometrial cells 
in culture exposure of the cells to estradiol resulted in the intracellular movement of both 
naER and Hsp-90. It was observed that both naER and Hsp-90 entered the nuclei within a 
matter of 3 hours following the exposure of the cells to estradiol. The functional significance 
of Hsp-90 in the nuclei remains to be known.naER is transformed into nuclear estrogen 
receptor II (nERII) within the nucleus. It is evident that this change in identity is associated 
with a distinct structural change in the protein. Possibly, this transformation that takes place 
within the nucleus is chaperoned by Hsp-90. 
12. Nuclear estrogen receptor II (nERII) 
Long before naER discovery became a reality, a nuclear receptor that was distinctly different 
from the classical estrogen receptors had come to my notice. It was observed that when 
uterine nuclei from ovarectomized rats were exposed to 10nM 3H-estradiol,at 30-370C, the 
hormone-binding component moved out of the nuclei and reached the outer medium within 
a span of 5 minutes after hormonal exposure (Thampan,1985;1988). What became apparent 
in the subsequent studies was that the hormone was bound to a class of ribonucleoproteins 
(RNP) that moved out of the nuclei following exposure to estradiol. Invivo studies involving 
ovariectomized rats demonstrated that the RNP that moved out of the nuclei was found 
associated with cytoplasmic polysomes. The results gave a clear indication to the possibility 
that a new class of estrogen receptors existed whose primary functional role was in post-
transcriptional control mechanisms like splicing, nucleocytoplasmic transport of RNP and 
the translation. 
The subsequent studies reported by our group(Jacob et al.,2006) presented systematic 
observations on both naER and nERII and concluded that the latter was a transformed form 
of the former. The observed differences between the two proteins are being listed 
below(Table 1). The methods employed for purifying the two proteins were identical. 
Going back to the observations related to E-RAF function (Thampan,1989), it may be recalled 
that the estrogen receptor function detected in close proximity to rat uterine nuclear RNA 
polymerases displayed both naER and nERII characteristics with nERII representing the major 
share of this activity. The naER existed in dimerisation with E-RAF.Later reports by 
Karthikeyan and Thampan (1996) showed that nERII tyrosine phosphorylated three subunits 
of nuclear RNA polymerase II.A re-examination of the 1989 report(Thampan,1989) will reveal 
that the naER/nERII interaction was not restricted to RNA polymerase II alone. There was 
very clear evidence to support the hypothesis that the receptor interacted with all four classes 
of nuclear RNA polymerases. Therefore, it may be speculated that nERII –mediated tyrosine 
phosphorylation involved specified subunits of all 4 categories of the enzyme. 
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 naER nERII 
Sedimentation Value 4.6S 3.7S 
Stokes radius 36A0 23 A0 
Glycoprotein nature Yes No 
Tyrosine kinase activity Sensitive to exposure to 
estradiol 
Insensitive to estradiol 
exposure 
Dimerisation with E-RAF Yes  No 
Interaction with Hsp-90 in the 
presence of estradiol 
No Yes 
nM estradiol needed for 
saturation binding 
20 30 
The factor responsible for this transformation was subsequently found to be a 61kDa protein, the naER 
transforming factor (Jaya & Thampan,2000). 
Table 1. Comparison of molecular properties associated with naER and nER II of the goat 
uterus 
13. Does tyrosine phosphorylation of a RNA polymerase subunit favour its 
dissociation from the core enzyme? 
The two models presented here (figures 6 and 7) make an attempt to find an explanation for 
the observations mentioned above. 
 
 
(1) Gene (2) RNA polymerase (3) RNA polymerase subunit that is recognized by naER (4) naER (5) E-
RAF (6) estradiol-17ǃ (7) spliceosome (8) nERII (9) RNA polymerase subunit phosphorylated by nERII 
(10) other subunits dissociated from the RNA polymerase (11) RNA (12) Nuclear pore complex (13) 
Nucleus (14) cytoplasm. 
Fig. 6. naER-nERII transformation during post transcriptional control of gene expression. 
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The figure on the left displays the interaction of naER-E-RAF heterodimer with genetic 
elements. While E-RAF recognizes the DNA, naER binds to nuclear RNA polymerase 
subunits. The figure on the right is a spliceosome -set -up in which the nERII –RNA complex 
is shown in association with subunits dissociated from RNA polymerase. 
nERII is a RNA binding estrogen receptor. Whether naER-E-RAF heterodimer has its 
binding site on the target gene different from those of the ERǂ/ERǃ mediated gene 
regulation or whether the action of the heterodimer is independent of the classical estrogen 
receptor function remains to be clarified. The binding site on the estrogen responsive target 
gene for E-RAF-naER heterodimer has not yet been identified while there is every likelihood 
to suggest that it will be different from the estrogen responsive element(ERE).A candidate 
site could well be AP-1 site in view of an earlier observation that c-fos and E-RAF share 
immunological similarity.  While E-RAF binds to the gene, naER interacts with the nuclear 
RNA polymerases. Possibly, the naER to nERII transformation could be an event that takes 
place at the end of the transcription process initiated by the heterodimer. At this stage, nERII 
dissociates from E-RAF and binds to the RNA (rRNA/mRNA/5S rRNA/tRNA). I wish to 
propose here that the phosphorylated subunits of the RNA polymerases might dissociate 
from the core enzyme and move along with nERII during the succeeding stages of gene 
regulation that witness splicing, nucleocytoplasmic transport and translation. 
Sebastian and Thampan (2002 a,b)and Sebastian et al(2004) presented some fascinating 
observations in this context. Goat uterine nERII was found to be associated with 
ribonucleoproteins containing U-1 and U-2 snRNA’s. Within the snRNP framework nERII 
interacted with three proteins with molecular masses 32kDa, 55kDa and 60kDa.While p55 
and p60 were found to be RNA binding proteins, p32 was found to be involved only in 
protein-protein interactions with nERII. Whether this protein is the same as SC35 reported 
by Parnaik in the context of spliceosome assembly (Tripathi & Parnaik,2008) remains to be 
seen. It was interesting to observe that nERII in association with p32 and p55 formed an 
effective Ca++/Mg++ activated ATPase that appeared to be directly involved in the 
nucleocytoplasmic movement of RNP. 
 
 
(1) nERII (2) rRNA (3) RNA polymerase I subunit(4)40S ribosomal subunit(5)60S ribosomal subunit. 
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The assumption is that nERII binding to subunits of RNA polymerase I, followed by nERII 
mediated tyrosine phosphorylation of those subunits results in the dissociation of the 
subunits from the enzyme along with the rRNA, remaining bound to nERII. The rRNA-
nERII-RNA polymerase I subunit complex is shown here as forming an integral part of the 
40S subunit of the ribosome.  
I wish to speculate here that the subunits dissociated form the RNA polymerases following 
phosphorylation by nERII could continue their association with nERII and find their 
involvement in splicing reactions, nucleocytoplasmic transport of RNA and eventually, in 
translation. If this assumption is correct, future studies on ribosomal subunits should be able 
to confirm the presence of RNA polymerase I and III subunits in 40S ribosomes. It should 
also be possible to confirm whether the RNA polymerase II subunits are present in 
spliceosomes. 
14. General conclusions and hypothetical possibilities 
1. Discussions exclusively on the classical estrogen receptors, ERǂ and ERǃ will serve to 
uncover only limited information on the role of the receptors in regulating gene 
expression. 
2. There is a distinct possibility that naER-E-RAF heterodimer has a parallel role to play in 
regulating transcriptional events as has been proposed for ERǂ and ERǃ. 
3. nERII is undoubtedly the estrogen receptor that mediates post transcriptional events in 
gene expression in estrogen target cells. 
4. The nERII-mediated events are related to gene expression protocols influenced by all 4 
forms of nuclear RNA polymerases. 
5. E-RAF targets both the nucleus and the mitochondria. Free E-RAF, progesterone-
bound E-RAF and cholesterol bound E-RAF encounter distinct genes that are under 
regulatory influence. It might function as cholesterol transporter to the mitochondria 
and facilitate mitochondrial steroidogenesis leading to the production of 
progesterone. This is, in all possibility, a mechanism projected to take place during 
pregnancy. 
6. The possibility exists that there is an “external”regulator of E-RAF gene expression and 
also that this regulatory agent is involved in the control of E-RAF gene expression in the 
pregnant uterus. 
7. The possibility for a role for E-RAF in the progression of mammary cancer cannot be 
ruled out. Studies to be held in the near future are bound to enlighten this possibility. 
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